LONDON, June 30, 2022 /PRNewswire/ -- Tetragon has
released its Monthly Factsheet for May
2022.
- Net Asset Value: $2,710m
- Fully Diluted NAV Per Share: $29.03
- Share Price (TFG NA): $10.30
- Monthly NAV per share total return: -1.4%
- Monthly Return on Equity: -0.9%
- Most recent quarterly dividend: $0.11
- Dividend yield: 4.1%
Please refer to important disclosures on page 3 of the
Monthly Factsheet.
Please click below to access the Monthly Factsheet.
May 2022 Factsheet
About Tetragon:
Tetragon is a closed-ended investment
company that invests in a broad range of assets, including public
and private equities and credit (including distressed securities
and structured credit), convertible bonds, real estate, venture
capital, infrastructure, bank loans and TFG Asset Management, a
diversified alternative asset management business. Where
appropriate, through TFG Asset Management, Tetragon seeks to own
all, or a portion, of asset management companies with which it
invests in order to enhance the returns achieved on its capital.
Tetragon's investment objective is to generate distributable income
and capital appreciation. It aims to provide stable returns to
investors across various credit, equity, interest rate, inflation
and real estate cycles. The company's non-voting shares are traded
on Euronext in Amsterdam, a
regulated market of Euronext Amsterdam N.V., and on the Specialist
Fund Segment of the main market of the London Stock Exchange. For
more information please visit the company's website at
www.tetragoninv.com.
Tetragon:
Yuko Thomas
Investor
Relations
ir@tetragoninv.com
|
Press
Inquiries:
Prosek
Partners
Pro-tetragon@prosek.com
United
States
Ryan
FitzGibbon Remy
Marin
+1 646 818
9298 +1 646 818 9234
|
United
Kingdom
Henrietta
Dehn
Alexa Bethell
+44 7717 281
665 +44 7940 166 251
|
This release does not contain or constitute an offer to sell or a
solicitation of an offer to purchase securities in the United States or any other jurisdiction.
The securities of Tetragon have not been and will not be registered
under the U.S. Securities Act of 1933 and may not be offered or
sold in the United States or to
U.S. persons unless they are registered under applicable law or
exempt from registration. Tetragon does not intend to register any
portion of its securities in the United
States or to conduct a public offer of securities in
the United States. In addition,
Tetragon has not been and will not be registered under the U.S.
Investment Company Act of 1940, and investors will not be entitled
to the benefits of such Act. Tetragon is registered in the public
register of the Netherlands Authority for the Financial Markets
under Section 1:107 of the Financial Markets Supervision Act as a
collective investment scheme from a designated country.